Nikhil Chopra Revised's most recent trade in J B Chemicals & Pharmaceuticals Ltd. was a Revoke of 15,000 Equity Shares done at an average price of Rs. 1755.0 . Disclosure was reported to the exchange on March 6, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Nikhil Chopra Revised in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J B Chemicals | Nikhil Chopra (Revised) | Director | Revoke | 06 Mar 2025 | 15,000 | 15,000 (0.01%) | 0.01% | 1755.0 | 26,325,134 | 02 Dec 2024 02 Dec 2024 |
Insider Trading | Equity Shares | Revocation Of Pledge |
J B Chemicals | Nikhil Chopra (Revised) | Director | Revoke | 06 Mar 2025 | 25,000 | 40,000 (0.03%) | 0.02% | 1736.3 | 43,406,359 | 29 Nov 2024 29 Nov 2024 |
Insider Trading | Equity Shares | Revocation Of Pledge |